Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

XOMA Corp (NASDAQ:XOMA)

7.52
Delayed Data
As of 4:00pm ET
 +0.05 / +0.67%
Today’s Change
3.96
Today|||52-Week Range
13.98
+78.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$56.8M

Company Description

XOMA Corp. engages in the discovery and development of innovative therapeutics derived from unique platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Berkeley, CA.

Contact Information

XOMA Corp.
2910 Seventh Street
Berkeley California 94710
P:(510) 204-7200
Investor Relations:
(510) 204-7482

Employees

Shareholders

Mutual fund holders6.03%
Other institutional30.52%
Individual stakeholders1.08%

Top Executives

James R. NealChief Executive Officer & Director
Thomas BurnsCFO, Principal Accounting Officer & VP-Finance
F. Allan GordonVice President-Clinical
Ashleigh BarretoInvestor Relations Contact
Denis J. QuinlanSecretary & Senior Corporate Counsel